Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Circulatory SystemDRG 313-chest-pain
    Ask Trek AI about this page

    Chest Pain: Inpatient Reimbursement Overview

    DRG 313 Chest Pain covers inpatient admissions focused on evaluation of chest pain without major cardiac complications; it includes resource use for diagnostic testing and observation. This Diagnosis-Related Group matters for inpatient reimbursement because assignment determines the bundled Medicare payment for the episode and affects hospital financial and clinical workflow.

    Customize your policy alerts

    Sign up for drg 313 policy alerts

    Get alerted when payer policies referencing 313 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 313 Overview

    DRG 313 Chest Pain encompasses hospital inpatient admissions primarily for evaluation and management of chest pain without a qualifying acute myocardial infarction, arrhythmia, or heart failure. This Diagnosis-Related Group captures resource use for diagnostic testing, observation, and short inpatient stays aimed at determining cardiac versus noncardiac causes. It matters for Medicare payment because classification into DRG 313 determines bundled reimbursement for the inpatient encounter and influences hospital revenue and length-of-stay management. Accurate coding of diagnoses and procedures is key to appropriate assignment to this Diagnosis-Related Group.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    National Payment Rates

    Across payers the observed rate range spans roughly $370 to $25K, with the widest spread between the lowest and highest reported payer values shown in the table and chart below. Among named payers, Aetna, Anthem, Blue Cross Blue Shield (BCBS), and Cigna display median and quartile differences that drive much of this range. Refer to the payer table and accompanying chart for detailed percentile breakdowns by payer.

    The CMS 2023 data represent national Medicare fee-for-service inpatient payments published under the CMS Provider Utilization and Payment Data program. The table below shows average total payment, average submitted covered charges, average Medicare payment amount, and total discharges for DRG 313. Values reflect Medicare FFS payment activity at the national level for 2023.

    Average Total PaymentAverage Submitted ChargesAverage Medicare PaymentTotal Discharges
    $6.9K$37K$5.2K22K

    Patient Population

    This DRG’s population is mixed but skews toward the Medicare-age cohort rather than exclusively working-age patients. Medicare fee-for-service discharges represent a substantial share of inpatient volume relative to commercial payers, while private/commercial coverage continues to contribute a meaningful portion of younger, working-age patients. Overall payer mix reflects both Medicare and commercial populations, with a tilt toward Medicare-age individuals.

    State Payment Rates

    State: Alaska1 / 49

    Alaska Benchmarks

    In Alaska, rates for DRG 313 range from $11K (Anthem and Blue Cross Blue Shield) to $17K (Cigna), a spread of about $6K across payers. Cigna’s mean sits above the state peers and represents the most notable deviation from the lower Anthem/BCBS rates. Reference the table and chart below for payer-level detail and distribution.

    Key Insights for Alaska

    • Highest payer: Cigna at $17K; Lowest payer: Anthem and BCBS at $11K each.
    • Cigna in Alaska pays notably above Anthem/BCBS by about $6K, and Cigna’s $17K mean is roughly in line with national Cigna benchmarks but higher than the state’s other payers.

    Clinical Trials

    • Acute diagnostic and risk-stratification trials: studies testing rapid diagnostic algorithms, point-of-care biomarkers, and imaging strategies in adult emergency department patients presenting with non-traumatic chest pain and suspected acute coronary syndrome. These trials enroll heterogeneous ED cohorts, often including low- to intermediate-risk patients, to evaluate time-to-diagnosis, safe discharge rates, and reductions in unnecessary hospital admissions. Results inform protocols that can reduce inpatient utilization and costs while ensuring high-risk patients are identified early, which is critical for both clinicians managing immediate care and payers controlling short-stay admissions for this DRG.
    • Comparative effectiveness studies of inpatient management pathways: randomized or observational studies comparing different inpatient care bundles (for example, observation-unit protocols versus full admission, expedited cardiology consultation versus standard care, or variations in telemetry and testing intensity) in patients admitted primarily for chest pain without initial evidence of myocardial infarction. These trials focus on length of stay, downstream testing, readmission rates, and diagnostic yield across typical chest-pain admission populations, including older adults and those with multiple comorbidities. Findings guide best practices for resource utilization and appropriate level-of-care decisions, directly impacting reimbursement, DRG assignment, and cost-containment strategies used by hospitals and payers.
    • Post-discharge outcomes and secondary prevention research: longitudinal cohort studies and interventional trials that follow patients discharged after a chest pain admission to evaluate adherence to follow-up testing, cardiovascular risk modification programs, and rates of major adverse cardiovascular events or repeat ED visits. These studies often target subgroups identified during the index visit (e.g., patients with non-obstructive coronary disease, unstable angina diagnosis, or multiple risk factors) to assess which discharge planning and outpatient interventions reduce recurrence and rehospitalization. Results are relevant to clinicians and payers because improved post-discharge management can lower readmission penalties, reduce long-term costs, and improve risk-adjusted outcomes associated with the DRG.

    Related Codes

    209-COMPLEX-AORTIC-ARCH-PROCEDURES

    Complex Aortic Arch Procedures: Inpatient Reimbursement Overview

    212-CONCOMITANT-AORTIC-AND-MITRAL-VALVE-PROCEDURES

    Concomitant Aortic and Mitral Valve Procedures: Inpatient Reimbursement Overview

    213-ENDOVASCULAR-ABDOMINAL-AORTA-WITH-ILIAC-BRANCH-PROCEDURES

    Endovascular Abdominal Aorta with Iliac Branch Procedures: Inpatient Reimbursement Overview

    215-OTHER-HEART-ASSIST-SYSTEM-IMPLANT

    Other Heart Assist System Implant: Inpatient Reimbursement Overview

    216-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITH-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with MCC: Inpatient Reimbursement Overview

    217-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITH-CC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization with CC: Inpatient Reimbursement Overview

    218-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITH-CARDIAC-CATHETERIZATION-WITHOUT-CC-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with Cardiac Catheterization without CC/MCC: Inpatient Reimbursement Overview

    219-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITH-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures with MCC: Inpatient Reimbursement Overview

    220-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITH-CC

    Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization with CC: Inpatient Reimbursement Overview

    221-CARDIAC-VALVE-AND-OTHER-MAJOR-CARDIOTHORACIC-PROCEDURES-WITHOUT-CARDIAC-CATHETERIZATION-WITHOUT-CC-MCC

    Cardiac Valve and Other Major Cardiothoracic Procedures without Cardiac Catheterization without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 100

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Mean Rates by Payer — National — DRG 313
    Mean Rates by Payer — Alaska — DRG 313